Abstract:
본발명은이퀄을유효성분으로함유하는후각과민증예방또는치료용약학조성물에관한것이다. 또한, 본발명은이퀄을유효성분으로함유하는후각과민증예방또는개선용건강기능식품에관한것이다. 또한, 본발명은이퀄을함유하는악취억제용방향제조성물에관한것이다. 본발명의이퀄을함유하는조성물은후각자극에의한 cAMP의생성을억제내지감소시켜다양한후각자극물질에대해뇌에서냄새인지를못하게하는역할을한다.
Abstract:
본 발명은 모시풀 추출물을 유효성분으로 함유하는 콜레스테롤 저감, 체중조절 및 비알코올성 지방간 개선용 건강기능식품 및 약학 조성물에 관한 것으로 모시풀 추출물을 유효성분으로 함유함으로써, 체내 혈당을 흡수하고 지방세포의 분화를 억제하며 지방간, 글루코오스, 지방함량을 감소시킬 수 있을 뿐만 아니라 독성이 없으므로 식품의 형태로 섭취할 수 있다.
Abstract:
The present invention provides various uses of a composition containing plant extracts from Lamiaceae, Liliaceae, or Amaranthaceae, associated with increased hTRPA1 activity; for example, use in screening pungent flavoring agents, diet pills, and hTRPA1 antagonist. The plant extracts from Lamiaceae, Liliaceae, or Amaranthaceae in the present invention provides various uses associated with hTRPA1 activation, and, being a natural compound, involves relatively few side effects in the body and has substantial industrial applicability. The plant extracts from Lamiaceae, Liliaceae, or Amaranthaceae in the present invention not only will be a novel medical or food raw material which is helpful in maintaining homeostasis in the body associated with hTRPA1 activation, but can also be used to provide an advantage in hTRPA1 antagonist screening.
Abstract:
PURPOSE: A pharmaceutical composition containing luteolin as an active ingredient for preventing and treating hyperosmia is provided to suppress recognition of disgusting smell from various olfactory stimulants by suppressing or reducing cyclic AMP (cAMP) generation, thereby effectively preventing and treating hyperosmia. CONSTITUTION: A pharmaceutical composition for preventing and treating hyperosmia contains luteolin as an active ingredient. Luteolin reduces cAMP concentration. The pharmaceutical composition is manufactured in a formulation selected from a group consisted of an oral formulation, an external use formulation, a suppository, a sterilized injection solution, and a spray. A health functional food for preventing and alleviating hyperosmia contains luteolin as an active ingredient. An aroma composition contains luteolin as an active ingredient.
Abstract:
PURPOSE: A pharmaceutical composition and health functional food containing selenomethionine are provided to prevent and treat obesity and lipid-related metabolic diseases. CONSTITUTION: A pharmaceutical composition for preventing and treating obesity and lipid-related metabolic diseases contains selenomethionine as an active ingredient. The pharmaceutical composition is manufactured in the form of powder, granules, tablets, capsules, suspension, emulsion, syrup, suppository, or sterilized injection solution. Selenomethionine suppresses differentiation of adipocyte. A health functional food contains selenomethionine as an active ingredient. The health functional food is used in the form of capsules, tablets, granules, powder, or beverage.